Hutch News
Search and Filter
Results per Page:
Immunotherapy trial in advanced bladder and other urinary tract cancers shows 'exciting' results
'Potentially practice-changing' data shows patients with advanced urothelial carcinoma survive longer with immune-boosting drug after chemo
'Everything we’ve been training for is happening now'
How early-career virologists dropped everything to seize the opportunity, and face the challenges, of studying the coronavirus
Stalled science, missed mates and virtual everything
Torn between science and safety concerns, young scientists navigate a new normal as they try to launch their careers
How COVID-19 has opened science
An urgent search for answers promotes a faster, freer exchange of ideas
Dr. Tom Lynch on the impact of COVID-19 on science
A conversation with the Fred Hutch president and director about open science, modeling, training and more
Public health’s pandemic pivot
With disease modeling, virtual events and a renewed focus on antiracism, Fred Hutch population scientists adapt their work to COVID-19
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of September 13, 2020
Braving the cold of Antarctica to raise money for cancer
Mitchel Beres ran 10 miles around McMurdo Station for Obliteride 2020
Experimental, precision strategy targets unique cancer protein found in certain acute myeloid leukemia cases
Lab study shows promise of aiming genetically engineered T-cell therapy at a gene fusion
Exercise video series for prostate cancer patients launches
A new resource designed to help improve patients’ overall quality of life
New insights into drug resistance in small cell lung cancer
Scientists discover a single gene’s outsized role in drug resistance — and use its vulnerability to re-sensitize tumors to chemotherapy in preclinical models
A cure for herpes? There is progress to report
Mouse studies show gene therapy can cause big drop in latent infections
What happens if the coronavirus’s spikes mutate?
First-of-its-kind study explores how changes in the virus’s ‘lock picks’ could help or hinder its ability to sneak into our cells
Obliteride brings in $2M to spur cancer, COVID-19 research
Annual Fred Hutch fundraiser goes virtual and DIY; sets records for participation, creativity and global reach
Computer model offers insights on COVID-19 super-spreading
New research compares transmission patterns of SARS-CoV-2 with those of influenza
Can a tumor that acts like a microbe help us develop better cancer therapies?
Understanding the genetics underlying spontaneous regression of an infectious tumor in Tasmanian devils could point us toward new treatment targets
Shifting liver cancer cells away from migratory state could reduce their drug resistance
Researchers hope lab-based study helps build foundation for personalized treatment of hepatocellular carcinoma
WATCH: Why Dr. Andrew Hsieh is optimistic about the future of treatment for bladder cancer
Physician-scientist aims to make a difference for patients with 'understudied' cancer
Dr. Rob Bradley named new McIlwain Family Endowed Chair in Data Science
Computational biologist uses data science to understand cancer biology and to seek new treatment targets
A path opens for precise analyses of breast cancer proteins
Paulovich lab runs CLIA-cleared tests to find patients appropriate for new HER2-targeted therapies
$3.4 million grant to find safer, more effective leukemia treatments
New combinatorial targeted therapies before haploidentical bone marrow transplantation for AML could also help expand access to potential cures for underserved populations